Carry-over [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2014-02-07 18:12 (4113 d 10:23 ago) – Posting: # 12370
Views: 17,296

Hi Lucas!

❝ ❝ For the 2x2x4 design the PASS calculations are moreover based on a model including carry-over. In today's time no one will use such an model.


❝ I'm sorry, but we may be a little outdated down here then. We do include carry-over in our replicate studies.


May I ask which code you are using?

❝ Where can I find more info about that to update our knowledge?


Well, this goody…

S Senn
Cross-over Trials in Clinical Research
John Wiley & Sons, Chichester (2nd ed 2002)
ISBN: 978-0-471-49653-3

…is essentially an essay against carry-over. If there is a true sequence effect (or more precisely unequal carry-over) you can’t do anything in the analysis. The treatment estimates will be biased. Since there is no method to deal with carry-over, the only option we have is to avoid it by design, i.e., sufficiently long wash-out periods.
You will find some stuff (and linked references) in the forum.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
172 visitors (0 registered, 172 guests [including 9 identified bots]).
Forum time: 05:35 CEST (Europe/Vienna)

Only dead fish go with the current.    Scuba divers' proverb

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5